308 related articles for article (PubMed ID: 27203153)
1. Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
Ong HL; Subramaniam M; Abdin E; Wang P; Vaingankar JA; Lee SP; Shafie S; Seow E; Chong SA
Psychiatry Res; 2016 Jul; 241():256-62. PubMed ID: 27203153
[TBL] [Abstract][Full Text] [Related]
2. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.
Candilis PJ; Fletcher KE; Geppert CM; Lidz CW; Appelbaum PS
Schizophr Res; 2008 Feb; 99(1-3):350-8. PubMed ID: 18164593
[TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
4. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
[TBL] [Abstract][Full Text] [Related]
5. Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia.
Gelder BM; Loughland CM; Carr VJ; Schofield PW
Acta Neuropsychiatr; 2015 Oct; 27(5):279-90. PubMed ID: 25959604
[TBL] [Abstract][Full Text] [Related]
6. Older patients with schizophrenia: nature of dwelling status and symptom severity.
Gupta S; Steinmeyer C; Frank B; Lockwood K; Lentz B; Schultz K
Am J Psychiatry; 2003 Feb; 160(2):383-4. PubMed ID: 12562592
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and length of hospital stay in older persons.
Binder EF; Robins LN
J Am Geriatr Soc; 1990 Jul; 38(7):759-66. PubMed ID: 2370396
[TBL] [Abstract][Full Text] [Related]
8. The Modified Mini-Mental State Examination test: normative data for Singapore Chinese older adults and its performance in detecting early cognitive impairment.
Feng L; Chong MS; Lim WS; Ng TP
Singapore Med J; 2012 Jul; 53(7):458-62. PubMed ID: 22815014
[TBL] [Abstract][Full Text] [Related]
9. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.
O'Reilly K; Donohoe G; Coyle C; O'Sullivan D; Rowe A; Losty M; McDonagh T; McGuinness L; Ennis Y; Watts E; Brennan L; Owens E; Davoren M; Mullaney R; Abidin Z; Kennedy HG
BMC Psychiatry; 2015 Jul; 15():155. PubMed ID: 26159728
[TBL] [Abstract][Full Text] [Related]
10. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia.
Heinik J
Int Psychogeriatr; 1998 Mar; 10(1):103-8. PubMed ID: 9629529
[TBL] [Abstract][Full Text] [Related]
11. Use of the mini-mental state exam in middle-aged and older outpatients with schizophrenia: cognitive impairment and its associations.
Moore DJ; Palmer BW; Jeste DV
Am J Geriatr Psychiatry; 2004; 12(4):412-9. PubMed ID: 15249279
[TBL] [Abstract][Full Text] [Related]
12. A snapshot of cognitive functioning: deriving a tool for the efficient assessment of cognition in schizophrenia and other chronic psychiatric disorders in a real-world inpatient setting.
Wong QJ; Miller M; Fiorito A; Ireland J
Psychiatry Res; 2013 Dec; 210(2):375-80. PubMed ID: 23916361
[TBL] [Abstract][Full Text] [Related]
13. Clock Drawing Test in patients with schizophrenia.
Bozikas VP; Kosmidis MH; Gamvrula K; Hatzigeorgiadou M; Kourtis A; Karavatos A
Psychiatry Res; 2004 Jan; 121(3):229-38. PubMed ID: 14675742
[TBL] [Abstract][Full Text] [Related]
14. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study.
Bora E; Yucel M; Pantelis C
Br J Psychiatry; 2009 Dec; 195(6):475-82. PubMed ID: 19949193
[TBL] [Abstract][Full Text] [Related]
15. Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.
Kao YC; Liu YP
BMC Psychiatry; 2010 Aug; 10():63. PubMed ID: 20718964
[TBL] [Abstract][Full Text] [Related]
16. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
[TBL] [Abstract][Full Text] [Related]
18. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
19. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
20. Cognitive functioning and insight in schizophrenia and in schizoaffective disorder.
Birindelli N; Montemagni C; Crivelli B; Bava I; Mancini I; Rocca P
Riv Psichiatr; 2014; 49(2):77-83. PubMed ID: 24770573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
